PharmaResearch Co., Ltd. (214450.KQ)
KRW 259500.0
(2.77%)
KRW 259500.0
(2.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 64.94 Billion | 59.4 Billion | 65.29 Billion | 32.39 Billion | 19.27 Billion | 5.2 Billion |
| Net Income | 76.55 Billion | 40.57 Billion | 46.68 Billion | 32.77 Billion | 16.66 Billion | 14.4 Billion |
| Depreciation & Amortization | 11.99 Billion | 10.74 Billion | 9.53 Billion | 8.36 Billion | 7.68 Billion | 5.02 Billion |
| Deferred income taxes | 530.27 Million | 1292.00 | -151.07 Million | -196.66 Million | -626.42 Million | -303.84 Million |
| Stock-based compensation | 657.1 Million | 505.87 Million | - | - | 2.91 Million | - |
| Change in working capital | -31.24 Billion | -10.46 Billion | 8.57 Billion | -9.97 Billion | -8.43 Billion | -1.68 Billion |
| Other non-cash items | 60.12 Billion | 52.59 Billion | 17.35 Billion | 31.5 Billion | 25.17 Billion | 2.32 Billion |
| Investing Cash Flow | -44.66 Billion | -11.9 Billion | -93.75 Billion | -36.2 Billion | -11.63 Billion | -18.37 Billion |
| Investments in PPE | -13.19 Billion | -17.75 Billion | -23.78 Billion | -35.38 Billion | -9.78 Billion | -29.43 Billion |
| Acquisitions | 28.65 Million | 161.44 Million | -2.39 Billion | 824.99 Thousand | 24.09 Million | -18.93 Billion |
| Investment purchases | -292.66 Billion | -308.05 Billion | -205.34 Billion | -89.94 Billion | -99.76 Billion | -84.7 Billion |
| Sales/Maturities of investments | 260.24 Billion | 313.01 Billion | 138.56 Billion | 86.31 Billion | 101.03 Billion | 108.91 Billion |
| Other Investing Activities | 925.68 Million | 729.48 Million | -3.18 Billion | 2.8 Billion | -3.14 Billion | 5.78 Billion |
| Financing Cash Flow | -25.96 Billion | -9.3 Billion | 42.96 Billion | 11.08 Billion | -9.1 Billion | 16.91 Billion |
| Debt repayment | -16.75 Billion | -1.37 Billion | -24.36 Billion | -14.55 Billion | -610 Million | -19.71 Billion |
| Dividends payments | -7.52 Billion | -6.31 Billion | -5.02 Billion | -2.94 Billion | -2.97 Billion | -2.8 Billion |
| Common Stock Repurchased | - | - | -49.36 Billion | - | -4.99 Billion | - |
| Common Stock Issuance | 359.23 Million | - | 25 Billion | - | 5.95 Billion | - |
| Other Financing Activities | -10.00 | -860 Million | -29.13 Million | -21.9 Million | -175.13 Million | 19.71 Billion |
| Accounts receivables | -269.99 Million | -4.77 Billion | -959.29 Million | -1.49 Billion | -2.54 Billion | -1.61 Billion |
| Accounts payables | -559.06 Million | 597.77 Million | 397.74 Million | -3.62 Billion | 504.45 Million | 2.73 Billion |
| Inventory | -28.18 Billion | -8.37 Billion | 2.92 Billion | -8.24 Billion | -3.79 Billion | -5.63 Billion |
| Other working capital | -2.22 Billion | 2.08 Billion | 6.2 Billion | 3.38 Billion | -2.6 Billion | 2.82 Billion |
| Cash at beginning of period | 72.93 Billion | 41.67 Billion | 26.71 Billion | 19.73 Billion | 21.09 Billion | 20.34 Billion |
| Cash at end of period | 67.24 Billion | 72.93 Billion | 41.67 Billion | 26.71 Billion | 19.73 Billion | 21.09 Billion |
| Capital Expenditure | -13.19 Billion | -17.75 Billion | -23.78 Billion | -35.38 Billion | -9.78 Billion | -29.43 Billion |
| Effect of forex changes on cash | 4.41 Million | -76.12 Million | 300.32 Million | -293.86 Million | 110.98 Million | 251.64 Million |
| Net cash flow / Change in cash | -5.68 Billion | 31.25 Billion | 14.95 Billion | 6.97 Billion | -1.35 Billion | 755.72 Million |
| Free Cash Flow | 51.74 Billion | 41.64 Billion | 41.5 Billion | -2.99 Billion | 9.48 Billion | -24.23 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 31.38 Billion | 17.24 Billion | 76.55 Billion | 15.4 Billion | 26.7 Billion | 16.73 Billion |
| Depreciation & Amortization | 3.14 Billion | 3.15 Billion | 11.99 Billion | 3.14 Billion | 3.06 Billion | 2.95 Billion |
| Deferred income taxes | - | - | 530.27 Million | 530.27 Million | - | -120.33 Million |
| Stock-based compensation | 163.82 Million | 163.82 Million | 657.1 Million | 165.62 Million | 165.62 Million | 163.82 Million |
| Change in working capital | -2.64 Billion | 6.82 Billion | -31.24 Billion | 3.71 Billion | -15.11 Billion | -10.91 Billion |
| Other non-cash items | -1.83 Billion | 8.15 Billion | 60.12 Billion | 7.16 Billion | 23.61 Billion | 19.52 Billion |
| Investing Cash Flow | -45.75 Billion | 9.26 Billion | -44.66 Billion | -20.1 Billion | -3.29 Billion | -15.6 Billion |
| Investments in PPE | -13.32 Billion | -5.15 Billion | -13.19 Billion | -3.87 Billion | -3.86 Billion | -2.36 Billion |
| Acquisitions | -582.18 Thousand | 22.4 Million | 28.65 Million | -113.46 Million | 42.91 Thousand | 35.29 Million |
| Investment purchases | -57.05 Billion | -45.33 Billion | -292.66 Billion | -55.53 Billion | -70.07 Billion | -91.95 Billion |
| Sales/Maturities of investments | 26.68 Billion | 59.93 Billion | 260.24 Billion | 39.17 Billion | 70.55 Billion | 78.52 Billion |
| Other Investing Activities | -32.42 Billion | -208.63 Million | 925.68 Million | 244.01 Million | 81.05 Million | 155.29 Million |
| Financing Cash Flow | -11.17 Billion | 10.17 Billion | -25.96 Billion | -16.14 Billion | -559.51 Million | -8.39 Billion |
| Debt repayment | -1.05 Billion | -10.64 Billion | -16.75 Billion | -13.52 Billion | -1.51 Billion | -174.97 Million |
| Dividends payments | -9.81 Billion | - | -7.52 Billion | -661.5 Million | - | -6.58 Billion |
| Common Stock Repurchased | - | - | - | - | - | -484.3 Million |
| Common Stock Issuance | - | - | 359.23 Million | - | - | 359.23 Million |
| Other Financing Activities | -301.2 Million | - | -10.00 | 10.74 Million | 1.49 Billion | -1.5 Billion |
| Accounts receivables | -887.25 Million | 1.14 Billion | -269.99 Million | 4.15 Billion | -4.43 Billion | -136.21 Million |
| Accounts payables | 1.2 Billion | 6.13 Billion | -559.06 Million | -2.77 Billion | -2.75 Billion | 4.22 Billion |
| Inventory | -2.49 Billion | -1.66 Billion | -28.18 Billion | -1.44 Billion | -9.17 Billion | -14.56 Billion |
| Other working capital | 737.34 Million | 1.2 Billion | -2.22 Billion | 3.76 Billion | 1.24 Billion | -433.06 Million |
| Cash at beginning of period | 121.6 Billion | 67.24 Billion | 72.93 Billion | 80.25 Billion | 68.09 Billion | 80.26 Billion |
| Cash at end of period | 95.07 Billion | 121.6 Billion | 67.24 Billion | 67.24 Billion | 80.25 Billion | 68.09 Billion |
| Capital Expenditure | -13.32 Billion | -5.15 Billion | -13.19 Billion | -3.87 Billion | -3.86 Billion | -2.36 Billion |
| Effect of forex changes on cash | 177.56 Million | 255.65 Million | 4.41 Million | -365.74 Million | 224.23 Million | 48.45 Million |
| Net cash flow / Change in cash | -26.53 Billion | 54.36 Billion | -5.68 Billion | -13 Billion | 12.15 Billion | -12.16 Billion |
| Free Cash Flow | 16.88 Billion | 29.51 Billion | 51.74 Billion | 19.73 Billion | 11.92 Billion | 9.41 Billion |
TMICY
0HCT
USBN
LPLA
002790
GSBC